These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 24231626)
1. Cetuximab and non-small-cell lung cancer: end of the story? Rossi A Lancet Oncol; 2013 Dec; 14(13):1251-3. PubMed ID: 24231626 [No Abstract] [Full Text] [Related]
3. Chemotherapy in stage III non-small cell lung cancer. Eberhardt WE; Hepp R Eur J Cancer; 2009 Sep; 45 Suppl 1():126-36. PubMed ID: 19775611 [No Abstract] [Full Text] [Related]
4. Docetaxel or pemetrexed with or without cetuximab in recurrent or progressive non-small-cell lung cancer after platinum-based therapy: a phase 3, open-label, randomised trial. Kim ES; Neubauer M; Cohn A; Schwartzberg L; Garbo L; Caton J; Robert F; Reynolds C; Katz T; Chittoor S; Simms L; Saxman S Lancet Oncol; 2013 Dec; 14(13):1326-36. PubMed ID: 24231627 [TBL] [Abstract][Full Text] [Related]
6. Randomized phase II study of cetuximab and bevacizumab in combination with two regimens of paclitaxel and carboplatin in chemonaive patients with stage IIIB/IV non-small-cell lung cancer. Bonomi PD; Mace J; Mandanas RA; Min M; Olsen M; Youssoufian H; Katz TL; Sheth G; Lee HJ J Thorac Oncol; 2013 Mar; 8(3):338-45. PubMed ID: 23370316 [TBL] [Abstract][Full Text] [Related]
12. [Chemotherapy in non-small-cell lung carcinoma. More than just promises?]. Feliu J; Ordóñez A; Espinosa J Med Clin (Barc); 1994 Jun; 103(2):72-5. PubMed ID: 8051975 [No Abstract] [Full Text] [Related]
13. Lung cancer with cavitation: a distinct subgroup of non-small cell lung cancer associated with poor overall survival. Singh N; Behera D Respir Investig; 2015 May; 53(3):133-4. PubMed ID: 25951101 [No Abstract] [Full Text] [Related]
14. [Role of chemotherapy in non-small cell lung carcinoma]. Giaccone G; Dingemans AM Ned Tijdschr Geneeskd; 1996 May; 140(21):1111-4. PubMed ID: 8692336 [No Abstract] [Full Text] [Related]
15. Carcinomatous meningitis in non-small-cell lung cancer: response to high-dose erlotinib. Dhruva N; Socinski MA J Clin Oncol; 2009 Aug; 27(22):e31-2. PubMed ID: 19487379 [No Abstract] [Full Text] [Related]
16. [Controversies in the treatment of non-small cell lung cancer; adjuvant chemotherapy]. Dediu M Pneumologia; 2001; 50(2):115-7. PubMed ID: 11584671 [No Abstract] [Full Text] [Related]
20. Adjuvant chemotherapy in new stage II pN0 non-small cell lung cancer: a new issue for a case-by-case decision making process. De Pas T; de Braud F; Veronesi G J Thorac Oncol; 2010 May; 5(5):754. PubMed ID: 20421773 [No Abstract] [Full Text] [Related] [Next] [New Search]